Point72 Asset Management
COLL icon

Point72 Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Point72 Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-952
Closed -$21.3K – 2257
2023
Q3 		$21.3K Buy
+952
New +$21.7K ﹤0.01% 2284
2023
Q2 		– Sell
-1,795
Closed -$43.1K – 2254
2023
Q1 		$43.1K Buy
+1,795
New +$47.6K ﹤0.01% 1813
2021
Q2 		– Sell
-133,522
Closed -$3.16M – 989
2021
Q1 		$3.16M Buy
+133,522
New +$3.17M 0.01% 662
2017
Q1 		– Sell
-28,000
Closed -$436K – 827
2016
Q4 		$436K Buy
+28,000
New +$465K ﹤0.01% 638

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's COLL Position: Q4 2023 in Review

Point72 Asset Management sold out of Collegium Pharmaceutical (COLL) in Q4 2023, closing a stake of 952 shares — an estimated $21.3K sold.

Point72 Asset Management first reported a position in COLL in Q4 2016 and held it in 4 quarters. The position peaked at $3.16M in Q1 2021. 193 funds tracked by Wall St. Rank hold COLL as of Q4 2023.

  • Point72 Asset Management reported no remaining Collegium Pharmaceutical position as of Q4 2023 after selling out during the quarter.
  • Point72 Asset Management sold 952 Collegium Pharmaceutical shares in Q4 2023, an estimated $21.3K.
  • Point72 Asset Management first reported a position in Collegium Pharmaceutical in Q4 2016 and held it in 4 quarters.
  • Point72 Asset Management's Collegium Pharmaceutical position peaked at $3.16M in Q1 2021.
  • 193 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q4 2023.

Based on Point72 Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.